Details of the Drug Reposition

General Information of This Drug (ID: DMCK2YR)

Drug Name
Sym022   DMCK2YR
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03489369) Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas. U.S. National Institutes of Health.